DE1617336C2 - Arzneimittel gegen Angina pectoris - Google Patents

Arzneimittel gegen Angina pectoris

Info

Publication number
DE1617336C2
DE1617336C2 DE19661617336 DE1617336A DE1617336C2 DE 1617336 C2 DE1617336 C2 DE 1617336C2 DE 19661617336 DE19661617336 DE 19661617336 DE 1617336 A DE1617336 A DE 1617336A DE 1617336 C2 DE1617336 C2 DE 1617336C2
Authority
DE
Germany
Prior art keywords
weight
angina pectoris
parts
active ingredients
medicines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE19661617336
Other languages
German (de)
English (en)
Other versions
DE1617336A1 (de
Inventor
Albrecht Dr. 6500 Mainz Engelhardt
Herbert Dr. 6507 Ingelheim Köppe
Arnhild Dr. 6507 Ingelheim Lichterfeld
Karl Prof. Dr. Zeile
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CH Boehringer Sohn AG and Co KG
Original Assignee
CH Boehringer Sohn AG and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CH Boehringer Sohn AG and Co KG filed Critical CH Boehringer Sohn AG and Co KG
Publication of DE1617336A1 publication Critical patent/DE1617336A1/de
Application granted granted Critical
Publication of DE1617336C2 publication Critical patent/DE1617336C2/de
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE19661617336 1966-11-25 1966-11-25 Arzneimittel gegen Angina pectoris Expired DE1617336C2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DEB0090017 1966-11-25

Publications (2)

Publication Number Publication Date
DE1617336A1 DE1617336A1 (de) 1970-12-10
DE1617336C2 true DE1617336C2 (de) 1982-07-01

Family

ID=6985072

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19661617336 Expired DE1617336C2 (de) 1966-11-25 1966-11-25 Arzneimittel gegen Angina pectoris

Country Status (5)

Country Link
BE (1) BE707050A (xx)
DE (1) DE1617336C2 (xx)
FR (1) FR7514M (xx)
GB (2) GB1194548A (xx)
IE (1) IE31963B1 (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3937834A (en) 1970-10-02 1976-02-10 Ciba-Geigy Corporation Pharmaceutical preparations
DE3833393A1 (de) * 1988-10-01 1990-04-05 Thomae Gmbh Dr K Verwendung von pteridinen zur verhinderung der primaeren und sekundaeren resistenz bei der chemotherapie und diese verbindungen enthaltende arzneimittel

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NICHTS-ERMITTELT

Also Published As

Publication number Publication date
DE1617336A1 (de) 1970-12-10
FR7514M (xx) 1969-12-15
BE707050A (xx) 1968-05-24
IE31963L (en) 1968-05-25
GB1201460A (en) 1970-08-05
GB1194548A (en) 1970-06-10
IE31963B1 (en) 1973-03-07

Similar Documents

Publication Publication Date Title
DE69420776T2 (de) Idebenone-haltige Zusammensetzungen zur Behandlung von M. Alzheimer
EP1513533B1 (de) Pharmazeutische wirkstoffkombination sowie deren verwendung
DE60204694T2 (de) Kombinationstherapie zur behandlung von herzinsuffizienz
DE1617336C2 (de) Arzneimittel gegen Angina pectoris
EP1001756B1 (de) Synergistisch wirkende zusammensetzungen zur selektiven bekämpfung von tumorgewebe
DE69625210T2 (de) Nicorandil gegen angstneurosen
DE3141970C2 (xx)
EP0219728B1 (de) Kombinationspräparat
DD294864A5 (de) Verwendung von naftopidil zur therapie der dysurie bei benigner prostata-hypertrophie
DE3736866A1 (de) Mittel zur behandlung des bluthochdrucks und der herzinsuffizienz
DE3213579C2 (xx)
DE2755017C2 (xx)
DE2952590A1 (de) Verwendung von pyridinderivaten zur behandlung von blutandrang verursachendem herzversagen
DE69936773T2 (de) Behandlung von depression und zusammensetzungen dazu
DE3511236C2 (xx)
DE2555609A1 (de) Pharmazeutisches praeparat zur therapie der hyperurikaemie
DE3880579T2 (de) Pharmazeutische zusammensetzungen zur behandlung der verstopfung der luftwege.
DE60016038T2 (de) Neue verwendung von levosimendan
EP1474134B1 (de) Kombinationspräparat des natrium-wasserstoff-austausch-inhibitors cariporide mit ramipril zur verhinderung bzw zur hemmung der herzinsuffizienz
DD283931A5 (de) Verfahren zur herstellung einer pharmazeutischen zusammensetzung zur behandlung von herzrhythmusstoerungen
EP0995441A2 (de) Medikamentenkombination zur Therapie der erektilen Dysfunktion
CH667388A5 (de) Pharmazeutische zubereitungen enthaltend 3-aminopropoxy-indole, bzw. 3-aminopropoxy-indole und diuretika, verwendung der wirkstoffe zur herstellung von pharmazeutischen zubereitungen.
DE3306128C2 (de) Pharmazeutische Verwendung von 2,4,6,8-Tetramethyl-2,4,6,8-tetraazobicyclo-[3,3,0]-oktandion-3,7
DE3920369A1 (de) Migraenemittel
DE2830044A1 (de) Pharmazeutisches praeparat zur behandlung von schlafstoerungen

Legal Events

Date Code Title Description
OI Miscellaneous see part 1
D2 Grant after examination
8339 Ceased/non-payment of the annual fee